STAND.
COM. REP. NO. 56-20
Honolulu, Hawaii
, 2020
RE: H.B. No. 1796
H.D. 1
Honorable Scott K. Saiki
Speaker, House of Representatives
Thirtieth State Legislature
Regular Session of 2020
State of Hawaii
Sir:
Your Committee on Health, to which was referred H.B. No. 1796 entitled:
"A BILL FOR AN ACT RELATING TO HEALTH,"
begs leave to report as follows:
Your Committee has amended this measure by:
(1) Deleting contents that would have placed a cap on the total amount that an insured is required to pay for a prescription insulin drug;
(2) Establishing the Insulin Drug Task Force within the Department of Commerce and Consumer Affairs to study whether cost-sharing limits should be placed on prescription insulin drugs;
(3) Changing the effective date to July 1, 2050, to encourage further discussion; and
(4) Making technical, nonsubstantive amendments for the purposes of clarity, consistency, and style.
As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 1796, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 1796, H.D. 1, and be referred to your Committee on Consumer Protection & Commerce.
Respectfully submitted on behalf of the members of the Committee on Health,
|
|
____________________________ JOHN M. MIZUNO, Chair |
|
|
|